{
    "title": "Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml",
    "link": "https://www.medscape.com/cx/rssfeeds/2700.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-11-19T22:13:49.640146",
    "items": [
        {
            "title": "‘Lean Diabetes’ a Risk Factor for Dementia?",
            "link": "https://www.medscape.com/viewarticle/metabolic-stress-not-body-weight-may-explain-dementia-risk-2025a1000wb3?src=rss",
            "description": "Clinicians may be overlooking ‘lean diabetes’ as a risk factor for dementia. Medscape Medical News",
            "pubDate": "2025-11-20T02:30:58",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Second Anti-HER2 TKI Approved for NSCLC",
            "link": "https://www.medscape.com/viewarticle/second-anti-her2-tki-approved-nsclc-2025a1000wan?src=rss",
            "description": "Bayer’s sevabertinib picks up a second-line indication for HER2-mutated disease, joining Boehringer’s zongertinib on the US market. Medscape Medical N...",
            "pubDate": "2025-11-19T20:59:32",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png"
        },
        {
            "title": "Checkpoint Inhibitor Prices Dropped Marginally Over Decade",
            "link": "https://www.medscape.com/viewarticle/checkpoint-inhibitor-prices-dropped-marginally-over-decade-2025a1000wa8?src=rss",
            "description": "A recent analysis reveals that monthly prices of checkpoint inhibitors decreased only a small amount over a decade. Medscape Medical News",
            "pubDate": "2025-11-19T19:34:22",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png"
        },
        {
            "title": "Allergy Therapy Shortcut? Omalizumab Speeds OIT Start",
            "link": "https://www.medscape.com/viewarticle/allergy-therapy-shortcut-omalizumab-speeds-oit-start-2025a1000wa7?src=rss",
            "description": "Children who received omalizumab pretreatment underwent less dose escalation in oral immunotherapy. Medscape Medical News",
            "pubDate": "2025-11-19T19:29:09",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png"
        },
        {
            "title": "Despite Risks, Safety Warnings, Valproate Use On the Rise",
            "link": "https://www.medscape.com/viewarticle/despite-risks-safety-warnings-global-valproate-use-continues-2025a1000w9z?src=rss",
            "description": "Even as newer antiseizure drugs surge, global prescribing remains anchored to valproate, signaling slow adoption of safety recommendations. Medscape M...",
            "pubDate": "2025-11-19T18:58:15",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        }
    ]
}